Flossie Wong-Staal
#29,913
Most Influential Person Now
American virologist
Flossie Wong-Staal's AcademicInfluence.com Rankings
Flossie Wong-Staalbiology Degrees
Biology
#2992
World Rank
#4646
Historical Rank
#1268
USA Rank
Virology
#78
World Rank
#81
Historical Rank
#27
USA Rank
Molecular Biology
#308
World Rank
#313
Historical Rank
#119
USA Rank
Download Badge
Biology
Why Is Flossie Wong-Staal Influential?
(Suggest an Edit or Addition)According to Wikipedia, Flossie Wong-Staal was a Chinese-American virologist and molecular biologist. She was the first scientist to clone HIV and determine the function of its genes, which was a major step in proving that HIV is the cause of AIDS. From 1990 to 2002, she held the Florence Riford Chair in AIDS Research at the University of California, San Diego . She was co-founder and, after retiring from UCSD, she became the chief scientific officer of Immusol, which was renamed Pharmaceuticals in 2007 when it transitioned to a drug development company focused on hepatitis C and continued as chief scientific officer.
Flossie Wong-Staal's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Complete nucleotide sequence of the AIDS virus, HTLV-III (1985) (2071)
- Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. (1986) (1435)
- Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients (1990) (895)
- Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). (1985) (788)
- Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS (1986) (784)
- Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. (1986) (712)
- HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA (1986) (600)
- The trans-activator gene of HTLV-III is essential for virus replication (1986) (594)
- Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein (1986) (570)
- onc gene amplification in promyelocytic leukaemia cell line HL-60 and primary leukaemic cells of the same patient (1982) (570)
- Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS. (1986) (559)
- Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome. (1984) (556)
- Human T-lymphotropic retroviruses (1985) (555)
- Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription. (1984) (543)
- AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. (1989) (488)
- Expression of cellular homologues of retroviral onc genes in human hematopoietic cells. (1982) (486)
- Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III. (1985) (477)
- The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats. (1985) (471)
- Cellular genes analogous to retroviral onc genes are transcribed in human tumour cells (1982) (454)
- Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat. (1985) (443)
- Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors (1998) (442)
- Dextran sulfate suppression of viruses in the HIV family: inhibition of virion binding to CD4+ cells. (1988) (439)
- Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions (1987) (430)
- Activation of the HIV-1 LTR by T cell mitogens and the trans-activator protein of HTLV-I. (1987) (406)
- Activation of interleukin 2 and interleukin 2 receptor (Tac) promoter expression by the trans-activator (tat) gene product of human T-cell leukemia virus, type I. (1987) (402)
- Sequence homology and morphologic similarity of HTLV-III and visna virus, a pathogenic lentivirus. (1985) (394)
- Dexamethasone-mediated inhibition of human T cell growth factor and gamma-interferon messenger RNA. (1984) (389)
- Regulation of the human interleukin-2 receptor α chain promoter: Activation of a nonfunctional promoter by the transactivator gene of HTLV-I (1987) (386)
- The sor gene of HIV-1 is required for efficient virus transmission in vitro. (1987) (382)
- Differential expression of the amv gene in human hematopoietic cells. (1982) (351)
- Multiple sclerosis and human T-cell lymphotropic retroviruses (1985) (330)
- Restricted expression of human T-cell leukemia--lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes. (1983) (325)
- Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6 (1989) (324)
- Complete nucleotide sequences of functional clones of the AIDS virus. (1987) (321)
- Molecular cloning and characterization of the HTLV-III virus associated with AIDS (1984) (318)
- Kaposi's sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4+ T cells. (1988) (309)
- A molecular clone of HTLV-III with biological activity (1985) (299)
- Cloning and characterization of different human sequences related to the onc gene (v-myc) of avian myelocytomatosis virus (MC29). (1982) (292)
- The biochemistry of AIDS. (1991) (292)
- Molecular biology of human T-lymphotropic retroviruses. (1985) (286)
- Biologically diverse molecular variants within a single HIV-1 isolate (1988) (282)
- Sequence of simian immunodeficiency virus and its relationship to the human immunodeficiency viruses (1987) (281)
- HTLV-III gag protein is processed in yeast cells by the virus pol-protease. (1986) (273)
- Development of lentiviral vectors for gene therapy for human diseases. (2000) (263)
- Neutralizing Antibody-Resistant Hepatitis C Virus Cell-to-Cell Transmission (2010) (262)
- A new reporter cell line to monitor HIV infection and drug susceptibility in vitro. (1997) (260)
- Identification of the fusion peptide of primate immunodeficiency viruses. (1989) (248)
- A novel integrin specificity exemplified by binding of the alpha v beta 5 integrin to the basic domain of the HIV Tat protein and vitronectin (1993) (244)
- Genomic analysis of the human B-lymphotropic virus (HBLV). (1986) (242)
- Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach. (2001) (240)
- Genomic diversity of human T-lymphotropic virus type III (HTLV-III). (1985) (230)
- Expression of the HTLV-III envelope gene by a recombinant vaccinia virus (1986) (226)
- Genomic diversity of the acquired immune deficiency syndrome virus HTLV-III: different viruses exhibit greatest divergence in their envelope genes. (1985) (222)
- Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cells. (1989) (215)
- Infectious mutants of HTLV-III with changes in the 3' region and markedly reduced cytopathic effects. (1986) (213)
- Human herpes virus‐6 increases HIV‐1 expression in co‐infected T cells via nuclear factors binding to the HIV‐1 enhancer. (1989) (211)
- Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes. (1991) (211)
- A hairpin ribozyme inhibits expression of diverse strains of human immunodeficiency virus type 1. (1993) (209)
- Progress towards gene therapy for HIV infection. (1994) (202)
- Inhibition of human immunodeficiency virus type 1 expression by a hairpin ribozyme. (1992) (200)
- Retroviruses as etiologic agents of some animal and human leukemias and lymphomas and as tools for elucidating the molecular mechanism of leukemogenesis. (1982) (192)
- A survey of human leukaemias for sequences of a human retrovirus (1983) (188)
- Antigens encoded by the 3'-terminal region of human T-cell leukemia virus: evidence for a functional gene. (1984) (172)
- Detection of HTLV-III RNA in lungs of patients with AIDS and pulmonary involvement. (1986) (171)
- Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells. (1990) (163)
- HIV/HTLV gene nomenclature (1988) (162)
- NR4A1, 2, 3--an orphan nuclear hormone receptor family involved in cell apoptosis and carcinogenesis. (2006) (155)
- Transformation of NIH 3T3 cells by a human c-sis cDNA clone (1984) (155)
- Inhibition of HIV replication by dominant negative mutants of Sam68, a functional homolog of HIV-1 Rev (1999) (154)
- A cellular cofactor for the constitutive transport element of type D retrovirus. (1997) (154)
- Site-directed mutagenesis of two trans-regulatory genes (tat-III,trs) of HIV-1. (1988) (153)
- Structure of 3' terminal region of type II human T lymphotropic virus: evidence for new coding region. (1984) (149)
- Detection of human B-lymphotropic virus (human herpesvirus 6) sequences in B cell lymphoma tissues of three patients. (1988) (149)
- Human-proto-oncogene nucleotide sequences corresponding to the transforming region of simian sarcoma virus. (1984) (149)
- Lentivirus replication and regulation. (1999) (148)
- Dendritic cells transduced by multiply deleted HIV-1 vectors exhibit normal phenotypes and functions and elicit an HIV-specific cytotoxic T-lymphocyte response in vitro. (2000) (147)
- NIH conference. T-cell lymphoproliferative syndrome associated with human T-cell leukemia/lymphoma virus. (1984) (147)
- Human T-cell leukemia virus (HTLV-I) transcripts in fresh and cultured cells of patients with adult T-cell leukemia. (1984) (146)
- A human onc gene homologous to the transforming gene (v-sis) of simian sarcoma virus (1981) (146)
- A role for RNA helicase A in post-transcriptional regulation of HIV type 1. (1999) (146)
- Pathogenesis of B cell lymphoma in a patient with AIDS. (1986) (146)
- A controlled, Phase 1 clinical trial to evaluate the safety and effects in HIV-1 infected humans of autologous lymphocytes transduced with a ribozyme that cleaves HIV-1 RNA. (1998) (144)
- Development of HIV vectors for anti-HIV gene therapy. (1996) (143)
- Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors. (2011) (142)
- Chromosomal sublocalization of human c-myb and c-fes cellular onc genes (1983) (133)
- Cytoplasmic localization of the HTLV-III 3' orf protein in cultured T cells. (1986) (133)
- T-cell growth factor gene: lack of expression in human T-cell leukemia-lymphoma virus-infected cells. (1984) (132)
- Development of novel cell surface CD34-targeted recombinant adenoassociated virus vectors for gene therapy. (1998) (128)
- Arginine Methylation of RNA Helicase A Determines Its Subcellular Localization* (2004) (127)
- Human immunodeficiency virus: the eighth gene. (1987) (125)
- Nuclear Hormone Receptor NR4A2 Is Involved in Cell Transformation and Apoptosis (2004) (124)
- Demonstration of virus-specific transcriptional activator(s) in cells infected with HTLV-III by an in vitro cell-free system (1986) (124)
- Exogenous tat protein activates human endothelial cells [see comments] (1993) (120)
- Long-term high-titer neutralizing activity induced by octameric synthetic HIV-1 antigen. (1991) (120)
- Identification of HTLV-III/LAV sor gene product and detection of antibodies in human sera. (1986) (119)
- Envelope sequences of two new United States HIV-1 isolates. (1988) (118)
- Characterization of long terminal repeat sequences of HTLV-III. (1985) (118)
- The molecular biology of the AIDS virus. (1988) (114)
- A plant-derived flavonoid inhibits entry of all HCV genotypes into human hepatocytes. (2012) (109)
- The family of human T-lymphotropic leukemia viruses: HTLV-I as the cause of adult T cell leukemia and HTLV-III as the cause of acquired immunodeficiency syndrome. (1985) (107)
- ORIGIN OF HUMAN T-CELL LEUKAEMIA-LYMPHOMA VIRUS (1983) (107)
- Transforming potential of human c-sis nucleotide sequences encoding platelet-derived growth factor. (1984) (107)
- Augmentation of human immunodeficiency virus type 1 gene expression by tumor necrosis factor alpha. (1989) (106)
- Type-restricted neutralization of molecular clones of human immunodeficiency virus. (1988) (106)
- Intracellular immunization of human T cells with a hairpin ribozyme against human immunodeficiency virus type 1. (1994) (105)
- Identification of a Human Immunodeficiency Virus Type 2 (HIV-2) Encapsidation Determinant and Transduction of Nondividing Human Cells by HIV-2-Based Lentivirus Vectors (1998) (104)
- Intracellular immunization of human fetal cord blood stem/progenitor cells with a ribozyme against human immunodeficiency virus type 1. (1995) (104)
- Transactivation induced by human T-lymphotropic virus type III (HTLV III) maps to a viral sequence encoding 58 amino acids and lacks tissue specificity. (1986) (102)
- HTLV-III, LAV, ARV are variants of same AIDS virus (1985) (95)
- Alteration of HIV-1 infectivity and neutralization by a single amino acid replacement in the V3 loop domain. (1991) (92)
- Gene for T-cell growth factor: location on human chromosome 4q and feline chromosome B1. (1984) (92)
- Identification of eIF2Bgamma and eIF2gamma as cofactors of hepatitis C virus internal ribosome entry site-mediated translation using a functional genomics approach. (2000) (91)
- Human T-cell lymphotropic virus type III shares sequence homology with a family of pathogenic lentiviruses. (1986) (91)
- Concomitant infection with HTLV-I and HTLV-III in a patient with T8 lymphoproliferative disease. (1986) (90)
- Transfer of an anti-HIV-1 ribozyme gene into primary human lymphocytes. (1994) (88)
- Synthesis of the complete trans-activation gene product of human T-lymphotropic virus type III in Escherichia coli: demonstration of immunogenicity in vivo and expression in vitro. (1986) (88)
- Sam68, RNA helicase A and Tap cooperate in the post-transcriptional regulation of human immunodeficiency virus and type D retroviral mRNA (2000) (85)
- RNA helicase A interacts with nuclear factor kappaB p65 and functions as a transcriptional coactivator. (2004) (85)
- Human T-cell growth factor: partial amino acid sequence, cDNA cloning, and organization and expression in normal and leukemic cells. (1984) (84)
- Genomes of evolutionarily divergent members of the human T-cell leukemia virus family (HTLV-I and HTLV-II) are highly conserved, especially in pX. (1984) (84)
- Sequence analysis of the V3 loop in brain and spleen of patients with HIV encephalitis. (1996) (84)
- Cell Surface CD4 Interferes with the Infectivity of HIV-1 Particles Released from T Cells* (2002) (83)
- Isolation and tissue distribution of type-C virus and viral components from a gibbon ape (Hylobates lar) with lymphocytic leukemia. (1978) (83)
- Oncogene expression in human leukemia. (1984) (83)
- A human T-lymphotropic retrovirus (HTLV-III) as the cause of the acquired immunodeficiency syndrome. (1985) (81)
- Missense mutations in an infectious human immunodeficiency viral genome: functional mapping of tat and identification of the rev splice acceptor. (1988) (80)
- Chromosomal assignment of the human homologues of feline sarcoma virus and avian myeloblastosis virus onc genes. (1982) (79)
- Functional interaction of the HTLV-1 transactivator Tax with activating transcription factor-4 (ATF4) (1997) (79)
- Involvement of Proteasome α-Subunit PSMA7 in Hepatitis C Virus Internal Ribosome Entry Site-Mediated Translation (2001) (78)
- Structural organization and expression of human DNA sequences related to the transforming gene of avian myeloblastosis virus. (1983) (76)
- Polymerase chain reaction amplification and in situ hybridization for the detection of human B-lymphotropic virus. (1988) (76)
- Differential response to the cytopathic effects of human T-cell lymphotropic virus type III (HTLV-III) superinfection in T4+ (helper) and T8+ (suppressor) T-cell clones transformed by HTLV-I. (1986) (75)
- HTLV-III env gene products synthesized in E. coli are recognized by antibodies present in the sera of AIDS patients (1985) (75)
- New human and simian HIV-related retroviruses possess functional transactivator (tat) gene (1987) (74)
- Molecular cloning and analysis of a new variant of human T‐cell leukemia virus (HTLV‐Ib) from an African patient with adult T‐cell leukemia‐lymphoma (1984) (74)
- Molecular studies of HHV-6. (1988) (73)
- onc sequences (v-fes) of Snyder–Theilen feline sarcoma virus are derived from noncontiguous regions of a cat cellular gene (c-fes) (1981) (73)
- Expression, purification, and renaturation of bone morphogenetic protein-2 from Escherichia coli. (2006) (73)
- Homology of genome of AIDS-associated virus with genomes of human T-cell leukemia viruses. (1984) (72)
- Clonal selection of T lymphocytes infected by cell-free human T-cell leukemia/lymphoma virus type I: parameters of virus integration and expression. (1985) (72)
- Efficient gene transfer by a human immunodeficiency virus type 1 (HIV-1)-derived vector utilizing a stable HIV packaging cell line. (1996) (71)
- Human T-cell leukemia-lymphoma virus (HTLV): cloning of an integrated defective provirus and flanking cellular sequences. (1983) (69)
- Genetic regulation of human immunodeficiency virus. (1991) (69)
- Nucleotide sequence analysis of a variant human T-cell leukemia virus (HTLV-Ib) provirus with a deletion in pX-I (1985) (68)
- One-week 96-well soft agar growth assay for cancer target validation. (2004) (67)
- Molecular cloning of a unique human T-cell leukemia virus (HTLV-IIMo). (1984) (67)
- Orphan G protein–coupled receptor GPR56 plays a role in cell transformation and tumorigenesis involving the cell adhesion pathway (2007) (65)
- Evaluation of ITX 5061, a scavenger receptor B1 antagonist: resistance selection and activity in combination with other hepatitis C virus antivirals. (2012) (65)
- Pyrvinium Targets the Unfolded Protein Response to Hypoglycemia and Its Anti-Tumor Activity Is Enhanced by Combination Therapy (2008) (64)
- Regulation of the human neurotropic virus promoter by JCV-T antigen and HIV-1 tat protein. (1990) (64)
- Role of the carboxy-terminal portion of the HIV-1 transmembrane protein in viral transmission and cytopathogenicity. (1989) (64)
- Repetitive structure in the long-terminal-repeat element of a type II human T-cell leukemia virus. (1984) (64)
- Hepatitis C virus infection of neuroepithelioma cell lines. (2010) (64)
- Inhibition of CCR5-dependent HIV-1 infection by hairpin ribozyme gene therapy against CC-chemokine receptor 5. (2000) (64)
- Identification of the human herpesvirus 6 glycoprotein H and putative large tegument protein genes (1991) (63)
- The Carboxyl Terminus of RNA Helicase A Contains a Bidirectional Nuclear Transport Domain (1999) (63)
- Long terminal repeat structure of an American isolate of type I human T-cell leukemia virus. (1984) (62)
- Identification and validation of a gene involved in anchorage-independent cell growth control using a library of randomized hairpin ribozymes. (2000) (62)
- The acidic amino-terminal region of the HIV-1 Tat protein constitutes an essential activating domain. (1989) (61)
- Molecular cloning and comparative analyses of the genomes of simian sarcoma virus and its associated helper virus. (1981) (60)
- Detection of Antibodies to Human T-Cell Lymphotropic Virus-III (HTLV-III) with an Immunoassay Employing a Recombinant Escherichia coli-Derived Viral Antigenic Peptide (1985) (59)
- Multigene antiviral vectors inhibit diverse human immunodeficiency virus type 1 clades (1997) (59)
- Structure of simian immunodeficiency virus regulatory genes. (1989) (58)
- The Control of Human Retrovirus Gene Expression (1988) (57)
- Nucleotide sequence of transforming human c-sis cDNA clones with homology to platelet-derived growth factor. (1985) (57)
- Development of new RNAi therapeutics. (2007) (56)
- In vitro and in vivo characterization of a second functional hairpin ribozyme against HIV-1. (1995) (56)
- A novel functional genomics approach identifies mTERT as a suppressor of fibroblast transformation (2000) (55)
- A chimeric human immunodeficiency virus type 1 (HIV-1) minimal Rev response element-ribozyme molecule exhibits dual antiviral function and inhibits cell-cell transmission of HIV-1 (1996) (55)
- Transduction of human macrophages using a stable HIV-1/HIV-2-derived gene delivery system (1998) (55)
- Proviral sequences of baboon endogenous type C RNA virus in DNA of human leukaemic tissues (1976) (54)
- Spectrum of natural antibodies against five HTLV-III antigens in infected individuals: correlation of antibody prevalence with clinical status. (1987) (54)
- Identification of Cellular Cofactors for Human Immunodeficiency Virus Replication via a Ribozyme-Based Genomics Approach (2004) (53)
- Trans-activating rev protein of the human immunodeficiency virus 1 interacts directly and specifically with its target RNA. (1990) (53)
- Safety and antiviral activity of the HCV entry inhibitor ITX5061 in treatment-naive HCV-infected adults: a randomized, double-blind, phase 1b study. (2014) (52)
- Sequence of the envelope glycoprotein gene of type II human T lymphotropic virus. (1984) (51)
- Approaches to gene therapy for human immunodeficiency virus infection. (2001) (51)
- Human gene marker/therapy clinical protocols. (1999) (51)
- Successful anti‐scavenger receptor class B type I (SR‐BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR‐BI‐targeting agents (2014) (50)
- Transcriptional activation from the long-terminal repeat of human immunodeficiency virus in vitro. (1990) (50)
- Exogenous tat protein activates human endothelial cells. (1993) (50)
- Specific cellular immune response and neutralizing antibodies in goats immunized with native or recombinant envelope proteins derived from human T-lymphotropic virus type IIIB and in human immunodeficiency virus-infected men. (1987) (50)
- Ribonucleotides in closed circular mitochondrial DNA from HeLa cells. (1973) (50)
- Activity and cleavage site specificity of an anti-HIV-1 hairpin ribozyme in human T cells. (1994) (50)
- Expression of ribozymes in gene transfer systems to modulate target RNA levels. (1998) (49)
- Retrovirus Biology and Human Disease (1989) (49)
- RNA interference and potential applications. (2006) (47)
- Dose-response resistance to HIV-1/MuLV pseudotype virus ex vivo in a hairpin ribozyme transgenic mouse model. (1999) (46)
- The human immunodeficiency virus type 2 (HIV-2) contains a novel gene encoding a 16 kD protein associated with mature virions. (1988) (46)
- Retroviral vectors expressing soluble CD4: a potential gene therapy for AIDS. (1990) (46)
- Murine intracisternal type A particles: a biochemical characterization (1975) (46)
- A Novel Shuttle Protein Binds to RNA Helicase A and Activates the Retroviral Constitutive Transport Element* (2000) (45)
- Primate type-C virus nucleic acid sequences (woolly monkey and baboon types) in tissues from a patient with acute myelogenous leukemia and in viruses isolated from cultured cells of the same patient. (1976) (45)
- Anti-HIV effects of HIV vectors. (1998) (44)
- Gene therapy targeting peripheral blood CD34+ hematopoietic stem cells of HIV-infected individuals. (1997) (43)
- Relative gene-silencing efficiencies of small interfering RNAs targeting sense and antisense transcripts from the same genetic locus. (2004) (43)
- An HTLV-III peptide produced by recombinant DNA is immunoreactive with sera from patients with AIDS (1985) (43)
- Describing Crouzon and Pfeiffer syndrome based on principal component analysis. (2015) (43)
- The v-sis transforming gene of simian sarcoma virus is a new onc gene of primate origin (1981) (42)
- Persistent infection of rhesus macaques with a molecular clone of human immunodeficiency virus type 2: evidence of minimal genetic drift and low pathogenetic effects (1990) (42)
- Phorbol diester induces expression of Tac antigen on human acute T lymphocytic leukemic cells. (1984) (42)
- Erratum: Inhibition of HIV replication by dominant negative mutants of Sam68, a functional homolog of HIV-1 Rev (Nature Medicine (1999) 5 (635- 642)) (1999) (42)
- Diagnostic potential for human malignancies of bacterially produced HTLV-I envelope protein. (1984) (42)
- Three distinct genes in human DNA related to the transforming genes of mammalian sarcoma retroviruses. (1981) (41)
- The HIV-1 HLA-A2-SLYNTVATL Is a Help-Independent CTL Epitope1 (2004) (41)
- A minimally replicative HIV-2 live-virus vaccine protects M. nemestrina from disease after HIV-2(287) challenge. (1998) (40)
- Inhibition of Rev activity and human immunodeficiency virus type 1 replication by antisense oligodeoxynucleotide phosphorothioate analogs directed against the Rev-responsive element (1993) (40)
- Localization of B-cell stimulatory activity of HIV-1 to the carboxyl terminus of gp41. (1990) (40)
- Retrovirus sequences in a leukemic gibbon and its contact: evidence for partial provirus in the nonleukemic gibbon. (1979) (39)
- Activation of tat-defective human immunodeficiency virus by ultraviolet light. (1990) (39)
- Functional interaction of Sam68 and heterogeneous nuclear ribonucleoprotein K (2002) (39)
- Isoginkgetin enhances adiponectin secretion from differentiated adiposarcoma cells via a novel pathway involving AMP-activated protein kinase. (2007) (39)
- Abundant transcription of a cellular gene in T cells infected with human T-cell leukemia-lymphoma virus. (1983) (39)
- Selective anticancer strategies via intervention of the death pathways relevant to cell transformation (2008) (38)
- Genetic relationship of a primate RNA tumour virus genome to genes in normal mice (1975) (38)
- Characterization of the endogenous feline leukemia virus-related DNA sequences in cats and attempts to identify exogenous viral sequences in tissues of virus-negative leukemic animals. (1980) (38)
- General effect of Sam68 on Rev/Rex regulated expression of complex retroviruses (2000) (37)
- Human gene (c-fes) related to the onc sequences of Snyder-Theilen feline sarcoma virus (1982) (37)
- Expression of the protein encoded by the 3' open reading frame of human T-cell lymphotropic virus type III in bacteria: demonstration of its immunoreactivity with human sera. (1986) (37)
- Differences in the interaction of HIV-1 and HIV-2 with CD4. (1990) (37)
- trans-Activation of the human T-cell leukemia virus long terminal repeat correlates with expression of the x-lor protein (1985) (37)
- Role of the fusogenic peptide sequence in syncytium induction and infectivity of human immunodeficiency virus type 2 (1992) (36)
- Ex vivo transduction and expansion of CD4+ lymphocytes from HIV + donors: prelude to a ribozyme gene therapy trial. (1996) (36)
- Gene therapy targeting cord blood-derived CD34+ cells from HIV-exposed infants: preclinical studies (1998) (36)
- Hybridization of potato spindle tuber viroid to cellular DNA of normal plants. (1976) (35)
- Serological cross-reactivity between envelope gene products of type I and type II human T-cell leukemia virus. (1984) (34)
- Genetic analysis of a new subgroup of human and simian T-lymphotropic retroviruses: HTLV-IV, LAV-2, SBL-6669, and STLV-IIIAGM. (1987) (34)
- Oncolytic virotherapy as a personalized cancer vaccine (2008) (33)
- POLYMERASE CHAIN REACTION AND IN-VITRO ANTIBODY PRODUCTION FOR EARLY DIAGNOSIS OF PAEDIATRIC HIV INFECTION (1988) (33)
- Tat-independent replication of human immunodeficiency viruses. (1995) (33)
- Further evaluation of soluble CD4 as an anti-HIV type 1 gene therapy: demonstration of protection of primary human peripheral blood lymphocytes from infection by HIV type 1. (1994) (33)
- Severe combined immunodeficiency mice engrafted with human T cells, B cells, and myeloid cells after transplantation with human fetal bone marrow or liver cells and implanted with human fetal thymus: a model for studying human gene therapy. (1997) (33)
- Genetic structure and regulation of HIV (1991) (33)
- Effect of Anti‐CD4 Antibody UB‐421 on HIV‐1 Rebound after Treatment Interruption (2019) (33)
- Comparative analyses of human immunodeficiency virus type 1 (HIV-1) and HIV-2 Vif mutants (1995) (32)
- Gibbon ape leukemia virus-Hall's Island: new strain of gibbon ape leukemia virus (1979) (31)
- Mapping the Functional Domains of HAP95, a Protein That Binds RNA Helicase A and Activates the Constitutive Transport Element of Type D Retroviruses* (2001) (31)
- Oncogenes: their role in neoplastic transformation. (1985) (31)
- 5' viral and human cellular sequences corresponding to the transforming gene of simian sarcoma virus. (1983) (31)
- Erratum: Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes (Proc. Natl. Acad. Sci. USA (June 1991) 88 (5011-5015)) (1992) (30)
- A Novel Integrin Specificity Exemplified by Binding of the av/35 Integrin to the Basic Domain of the HIV Tat Protein and Vitronectin (2002) (30)
- A more efficient RNAi inducible system for tight regulation of gene expression in mammalian cells and xenograft animals. (2007) (30)
- Biochemical characterization of genetic mutations of GPR56 in patients with bilateral frontoparietal polymicrogyria (BFPP). (2008) (30)
- A Role for KH Domain Proteins (Sam68-like Mammalian Proteins and Quaking Proteins) in the Post-transcriptional Regulation of HIV Replication* (2002) (30)
- Identification and purification of cellular proteins that specifically interact with the RNA constitutive transport elements from retrovirus D. (1997) (28)
- Targeting HCV Entry For Development of Therapeutics (2010) (27)
- Specific interaction of HTLV tax protein and a human type IV neuronal intermediate filament protein. (1998) (27)
- Transduction of cell lines and primary cells by FIV-packaged HIV vectors. (2004) (27)
- Common site of integration of HTLV in cells of three patients with mature T-cell leukaemia-lymphoma (1983) (26)
- Comparisons of RNAi approaches for validation of human RNA helicase A as an essential factor in hepatitis C virus replication. (2008) (25)
- Recognition of engineered tRNAs with an extended 3' end by Exportin-t (Xpo-t) and transport of tRNA-attached ribozymes to the cytoplasm in somatic cells. (2001) (25)
- Human immunodeficiency virus type 2 (HIV-2) vector-mediated in vivo gene transfer into adult rabbit retina (2002) (25)
- Increased titer of recombinant AAV vectors by gene transfer with adenovirus coupled to DNA-polylysine complexes. (1995) (25)
- Effect of scavenger receptor class B type I antagonist ITX5061 in patients with hepatitis C virus infection undergoing liver transplantation (2016) (25)
- Identification and characterization of a nuclear factor that specifically binds to the Rev response element (RRE) of human immunodeficiency virus type 1 (HIV-1). (1991) (25)
- HTLV-III and the etiology of AIDS. (1986) (24)
- Conservative mutations in the putative metal-binding region of human immunodeficiency virus tat disrupt virus replication. (1990) (24)
- Current thoughts on the viral etiology of certain human cancers: The Richard and Hinda Rosenthal Foundation Award lecture. (1984) (24)
- A Novel hnRNP Specifically Interacts with HIV-1 RRE RNA. (1996) (24)
- HTLV-I infection of T and B cells of a patient with adult T-cell leukemia-lymphoma (ATLL) and transmission of HTLV-I from B cells to normal T cells. (1985) (24)
- AIDS Research Reviews (1991) (23)
- Screening of small-molecule compounds as inhibitors of HCV entry. (2009) (23)
- Discovery of ITX 4520: a highly potent orally bioavailable hepatitis C virus entry inhibitor. (2012) (22)
- Activation ofinterleukin 2andinterleukin 2receptor (Tac) promoter expression bythetrans-activator (tat) gene product ofhumanT-cell leukemia virus, typeI (1987) (22)
- Mapping the determinants of human immunodeficiency virus 2 for infectivity, replication efficiency, and cytopathicity. (1993) (22)
- A new inducible RNAi xenograft model for assessing the staged tumor response to mTOR silencing. (2006) (22)
- Discovery of highly potent small molecule Hepatitis C Virus entry inhibitors. (2011) (21)
- Biological characterization of noninfectious HIV-1 particles lacking the envelope protein. (1992) (21)
- Human T-cell leukemia virus I provirus and antibodies in a captive gorilla with non-Hodgkin's lymphoma. (1986) (20)
- Comparative restriction endonuclease maps of proviral DNA of the primate type C simian sarcoma-associated virus and gibbon ape leukemia virus group (1982) (20)
- Common site of integration of HTLV in cells of three patients with mature T-cell leukaemia–lymphoma: a retraction (1983) (20)
- Localization of human immunodeficiency virus Rev in transfected and virus-infected cells. (1995) (20)
- Nucleotide sequence analysis of the env gene of a new Zairian isolate of HIV-1. (1988) (20)
- The human onc gene c-myc: structure, expression, and amplification in the human promyelocytic leukemia cell line HL-60. (1983) (20)
- Molecular and immunologic analysis of a chronic lymphocytic leukemia case with antibodies against human T‐cell leukemia virus (1985) (19)
- HIV-2 and SIV Vector Systems (2001) (19)
- Use of ribozymes to inhibit gene expression. (1999) (19)
- Transduction of CD34+ cells by a vesicular stomach virus protein G (VSV-G) pseudotyped HIV-1 vector. Stable gene expression in progeny cells, including dendritic cells. (1998) (19)
- Toxicity and Intraocular Properties of a Novel Long-Acting Anti-Proliferative and Anti-Angiogenic Compound IMS2186 (2008) (18)
- Molecular analysis of a deletion mutant provirus of type I human T-cell lymphotropic virus: evidence for a doubly spliced x-lor mRNA. (1986) (18)
- Transcriptional regulation of a tumor promoter and mitogen-inducible gene in human lymphocytes (1984) (18)
- Intracellular Immunization of Rhesus CD34+ Hematopoietic Progenitor Cells With a Hairpin Ribozyme Protects T Cells and Macrophages From Simian Immunodeficiency Virus Infection (1997) (17)
- AIDS Vaccine Research (2002) (17)
- PHTS, a novel putative tumor suppressor, is involved in the transformation reversion of HeLaHF cells independently of the p53 pathway. (2006) (17)
- Transdominant inhibition of wild-type human immunodeficiency virus type 2 replication by an envelope deletion mutant (1993) (17)
- Molecular cloning and characterization of a TAR-binding nuclear factor from T cells. (1995) (17)
- Inverse Genomics™ as a powerful tool to identify novel targets for the treatment of neurodegenerative diseases (2003) (16)
- Mobilization of peripheral blood progenitor cells for human immunodeficiency virus-infected individuals. (1999) (15)
- Identification and mapping of inhibitory sequences in the human immunodeficiency virus type 2 vif gene (1995) (15)
- Patient-Specific Implant for Residual Facial Asymmetry following Orthognathic Surgery in Unilateral Craniofacial Microsomia (2016) (15)
- T cell malignancies and human T cell leukemia virus. (1984) (14)
- Identification of a mutation in chloroplast DNA correlated with formation of defective chloroplasts in a variegated mutant of Nicotiana tabacum (1973) (14)
- Inhibition of HIV Replication by the Hairpin Ribozyme (1996) (14)
- Intracellular immunization of rhesus CD34+ hematopoietic progenitor cells with a hairpin ribozyme protects T cells and macrophages from simian immunodeficiency virus infection. (1997) (14)
- Conservation of a hairpin ribozyme sequence in HIV-1 is required for efficient viral replication. (1996) (14)
- A method for detecting and preventing negative RNA interference in preparation of lentiviral vectors for siRNA delivery. (2009) (13)
- Characterization of murine monoclonal antibodies to HIV-1 induced by synthetic peptides. (1988) (13)
- Novel technologies for studying virus-host interaction and discovering new drug targets for HCV and HIV. (2002) (13)
- Maternal inheritance, cytology and macromolecular composition of defective chloroplasts in a variegated mutant of Nicotiana tabacum (1973) (13)
- Complete nucleotide sequences of functional clones of the virus associated with the acquired immunodeficiency syndrome, HTLV-III/LAV. (1987) (13)
- Deletions of specific regions of the simian sarcoma-associated virus genome are found in defective viruses and in the simian sarcoma virus (1982) (13)
- A 96-well surrogate survival assay coupled with a special short interfering RNA vector for assessing cancer gene targets with enhanced signal/noise ratio and its utility in HTS for cancer therapeutic targets. (2005) (12)
- Describing the mandible in patients with craniofacial microsomia based on principal component analysis and thin plate spline video analysis. (2019) (12)
- A novel RNAi library based on partially randomized consensus sequences of nuclear receptors: identifying the receptors involved in amyloid beta degradation. (2006) (12)
- Regulatory genes of human immunodeficiency viruses. (1992) (12)
- Reactivity of E. coli-derived trans-activating protein of human T lymphotropic virus type III with sera from patients with acquired immune deficiency syndrome. (1986) (12)
- Molecular cloning of circular unintegrated DNA of two types of the SEATO strain of gibbon ape leukemia virus (1982) (12)
- Genetic Regulation of HIV (1989) (12)
- Distribution of feline leukemia virus DNA sequences in tissues of normal and leukemic domestic cats. (1979) (11)
- Ribozyme gene therapy for HIV infection Intracellular immunization of lymphocytes and CD34+ cells with an anti-HIV-1 ribozyme gene (1995) (11)
- Divergence of baboon endogenous type C virogenes in primates: genomic viral RNA in molecular hybridization experiments (1977) (11)
- Inhibition of HIV replication by dominant negative mutants of Sam68, a functional homolog of HIV-1 Rev (1999) (11)
- Ribozyme technology for cancer gene target identification and validation. (2007) (11)
- Stem cells as vehicles for gene therapy: Novel strategy for hiv infection (1995) (11)
- Ribozymes in gene identification, target validation and drug discovery (2004) (11)
- The simian immunodeficiency virus envelope open reading frame located after the termination codon is expressed in vivo in infected animals. (1988) (10)
- SOME EVIDENCE FOR INFECTIOUS TYPE-C VIRUS IN HUMANS (1976) (10)
- Intracellular immunization against SIVmac utilizing a hairpin ribozyme. (1996) (10)
- Nonrandom distribution of antibodies to the TRS protein of human immunodeficiency virus in infected people with different clinical status. (1988) (10)
- Human retroviruses with emphasis on HTLV-III/LAV: Now and future perspectives (1987) (10)
- A lymphoproliferative disorder caused by human T-lymphotropic virus type I. Demonstration of a continuum between acute and chronic adult T-cell leukemia/lymphoma. (1987) (10)
- Recent development of RNAi in drug target discovery and validation. (2006) (10)
- Genetic Variation in a Human Immunodeficiency Virus Type 2 Live-Virus Macaca nemestrina Vaccine Model (1998) (10)
- Detection of HTLV-I (human T-cell lymphotropic virus, type I) proviral DNA in leukemic cells from a French patient with Sezary syndrome. (1986) (10)
- Activation of a novel KpnI transcript by downstream integration of a human T-lymphotropic virus type I provirus. (1986) (9)
- The promoter of human T-cell leukemia virus type-I is repressed by the immediate-early gene region of human cytomegalovirus in primary blood lymphocytes. (1991) (9)
- Molecular studies of human T-cell leukemia virus and adult T-cell leukemia. (1984) (9)
- Gene therapy and HIV disease. (1995) (9)
- Hormone Receptor Regulation of the Human Immunodeficiency Virus Type 1 and Type 2 Long Terminal Repeats. (1996) (9)
- Differential expression of the amy gene in human hematopoietic cells (8)
- Characterization of a molecular clone of HIV type 2 infectious for Macaca nemestrina. (1998) (8)
- Viruses and Adult Leukemia — Lymphoma of Man and Relevant Animal Models (1982) (8)
- C-SPACE (cleavage-specific amplification of cDNA ends): a novel method of ribozyme-mediated gene identification. (2001) (7)
- Human T-lymphotropic viruses. (2020) (7)
- Generation of dendritic cells from lentiviral vector‐transduced CD34+ cells from HIV+ donors (2003) (7)
- Molecular characterization of human T-lymphotropic leukemia virus type III associated with the acquired immunodeficiency syndrome. (1984) (7)
- 3 – Human Immunodeficiency Virus (HIV) Gene Structure and Genetic Diversity (1991) (7)
- MDDD, a 4,9-diazapyrenium derivative, is selectively toxic to glioma cells by inducing growth arrest at G0/G1 independently of p53 (2006) (6)
- A recombinant clone of HIV-1 preferentially transmitted in normal peripheral blood mononuclear cells. (1989) (6)
- Lack of expression of cellular homologues of retroviral onc genes in bovine tumors. (1983) (6)
- An infectious chimeric human immunodeficiency virus type 2 (HIV-2) expressing the HIV-1 principal neutralizing determinant (1995) (6)
- Human immunodeficiency virus type 1 rev protein as a negative trans-regulator. (1989) (6)
- Genomic diversity of Zairian HIV isolates: biological characteristics and clinical manifestation of HIV infection. (1987) (6)
- Generation of shRNA Pool Library: A Revision of the Biological Technique from the Viewpoint of Chemistry (2008) (6)
- Interaction of viral and cellular factors with the HTLV-III LTR target sequences in vitro. (1987) (6)
- Molecular biology of HIV: challenges for the second decade. (1994) (5)
- Restricted expression of integrated primate type-C virus (gibbon ape leukemia virus-simian sarcoma virus) proviral DNA in nonproductively infected human B lymphoblasts. (1982) (5)
- Development of ribozyme gene therapy for HIV infection. (1996) (5)
- One-step, highly efficient site-directed mutagenesis by toxic protein selection. (2002) (5)
- Rearrangement and enhanced expression of c-myc oncogene in fresh tumor cells obtained from a patient with acute lymphoblastic leukemia. (1986) (5)
- Structure of the long terminal repeat of simian lymphotropic virus type III (African green monkey) and its relatedness to that of HIV. (1987) (5)
- Virus-based vectors for gene expression in mammalian cells: Lentiviruses (2003) (5)
- Human immunodeficiency virus: genetic structure and function. (1988) (5)
- In vitro characterization of a biologically active molecular clone of HIV-2NIH-Z containing a nef deletion and expressing a full-length transmembrane protein. (1990) (5)
- HTLV-III/LAV and the origin and pathogenesis of AIDS. (1987) (4)
- The AIDS virus. What we know and what we can do about it. (1991) (4)
- Production, purification, and serologic application of a recombinant peptide from the carboxyl terminus of the χ gene protein of human T-cell lymphotropic virus type I (1986) (4)
- The human T-cell leukemia-lymphoma virus family. (1985) (4)
- A Human T-Lymphotropic Retrovirus (HTLV-III) as the Cause of the Acquired Immunodeficiency Syndrome (1986) (4)
- HIV-1 expression is posttranscriptionally repressed in Drosophila cells. (1989) (4)
- Determination of a splice acceptor site of pX gene in HTLV-I infected cells. (1985) (4)
- Detection of integrated type-C viral DNA fragments in two primates (human and gibbon) by the restriction enzyme blotting technique. (1979) (4)
- Name for AIDS virus (1985) (4)
- Transcellular activation of the HTLV promoter by human hematopoietic cells. (1994) (3)
- Production of oncogene-specific proteins and human T-cell leukemia (lymphotropic) retrovirus (HTLV-I) envelope protein in bacteria and its potential for use in human cancers and seroepidemiological surveys. (1985) (3)
- A Disulfide-Bound HIV-1 V3 Loop Sequence on the Surface of Human Rhinovirus 14 Induces Neutralizing Responses against HIV-1 (1999) (3)
- Ribozymes in Cancer Gene Therapy (2002) (3)
- Heteroduplex mapping in the molecular analysis of the human T-cell leukemia (lymphotropic) viruses. (1985) (3)
- Gene therapy and the two faces of HIV (2000) (3)
- Integrated approaches to therapeutic target gene discovery. (2002) (3)
- Nucleotide Sequence Analysis of a Variant Human T-Cell Leukemia Virus ( HTLV-Ib ) Provirus with a Deletion in pXI (3)
- Cloning and characterization of different human sequences related to the onc gene ( v-myc ) of avian myelocytomatosis virus ( MC 29 ) ( type C RNA tumor virus / onc genes ) (2003) (3)
- The oncogene and its potential role in carcinogenesis. (1985) (2)
- Unintegrated and integrated proviruses of two strains of baboon endogenous viruses: comparative restriction endonuclease analysis. (1981) (2)
- Human T-cell leukemia-lymphoma virus (HTLV): a progress report. (1983) (2)
- Genetic regulation of human immunodeficiency virus (1991) (2)
- Molecular Biology of HTLV (1984) (2)
- Minimal FLAG Sequence Useful in the Functional Epitope Tagging of HRas (2)
- Baboon endogenous virus genomes in four species of baboons and five other genera of Old World monkeys: evidence for infection postspeciation. (1981) (2)
- HIV gene regulation and pathogenesis. (1989) (2)
- Itx 5061 Quantitation in Human Plasma with Reverse Phase Liquid Chromatography and Mass Spectrometry Detection (2013) (2)
- Highlights from the University of California San Diego Center for AIDS Research. (1997) (2)
- Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes. (1992) (2)
- 10 – Molecular Aspects of HIV: Mechanisms of Gene Regulation and Immune Evasion (1989) (2)
- Human T-Cell Growth Factor, Growth of Human Neoplastic T Cells, and Human T-Cell Leukemia-Lymphoma Virus (1984) (2)
- Effect of scavenger receptor B-I antagonist, ITX5061, on early hepatitis C virus kinetics in liver transplantation: results of a phase 1b clinical trial (2014) (2)
- Cellular onc genes: their role as progenitors of viral onc genes and their expression in human cells. (1983) (1)
- Orphan G-protein coupled receptor GPCR-X as a novel cancer drug target: validation and mechanistic studies (2005) (1)
- Recombinant virus coat protein associated with "Acquired Immune Deficiency Syndrome" (AIDS), and methods for testing of AIDS. (1986) (1)
- A rapid and sensitive assay for proviral sequences of a human retrovirus (HTLV) in leukemic cells. (1983) (1)
- Expression ofcellular homologues ofretroviral onegenesinhuman hematopoietic cells (1982) (1)
- HTLV-III and the Etiology of AIDS (Part 2 of 2) (1986) (1)
- Altered immunophenotype of dendritic cells generated from HIV infected subjects. (2001) (1)
- Virology Flossie Wong-Staal and Jaap Goudsmit (1991) (1)
- Seroepidemiological evidence for HTLV-III infection as the primary etiologic factor for acquired immunodeficiency syndrome. (1985) (1)
- Variation of the HIV Genome: Implications for the Pathogenesis and Prevention of AIDS (2018) (1)
- Human T-cell leukemia-lymphoma virus ( HTLV ) : Cloning of an integrated defective provirus and flanking cellular sequences ( human type C retrovirus / T-cell leukemia / molecular cloning / integrated provirus ) (1)
- Detection of rare cells expressing HTLV-III in primary lymphoid tissue from infected individuals using a highly sensitive in situ hybridization method (1986) (1)
- HCV Viral Entry Inhibitors (2011) (1)
- Scavenger receptor B-I antagonist ITX5061 modulates early HCV kinetics in patients undergoing liver transplantation: results of a phase Ib clinical trial (2013) (1)
- Some perspectives on the molecular mechanism of in vitro transformation and in vivo leukemogenesis by HTLV. (1985) (1)
- Molecular cloning of a unique human T-cell leukemia virus ( HTLV-IIM 0 ) ( human type C retrovirus / integrated provirus ) (1)
- Human T-cell leukemia-lymphoma virus (HTLV) and human viral onc gene homologues. (1983) (1)
- AG126 Protects ARPE–19 Cells From Oxidative Stress via a Mechanism Dependent on RNA Transcription (2005) (0)
- Role of the Human Retroviruses HTLV-I, HTLV-II and HIV in Leukemia and AIDS (1988) (0)
- Molecular Biology of Viruses of the HTLV Family (1985) (0)
- Novel replication competent human immunodeficiency virus type 2 (hiv-2) proviral clone designated hiv-2kr (1997) (0)
- Molecular cloning of a unique humz (2016) (0)
- Transdominant Rev and Protease Mutant Proteins of HIV-SIV as Potential Antiviral Agents in Vitro and in Vivo (AIDS) (1993) (0)
- 21 Advances in Gene Therapy for HIV and Other Viral Infections (1999) (0)
- Contents, Vol. 82, 1987 (1987) (0)
- Methods for Treating HIV by Gene Therapy Using Ribozymes (1998) (0)
- Productionof OncogenespecificProteinsand HumanTCeH Leukemia (Lymphotropic) Retrovirus(HTLVI) EnvelopeProteinin Bacteriaand Its Potentialfor Usein HumanCancersand Seroepidemiological Surveys (1985) (0)
- Type-specific and cross-reactive neutralizing antisera against HIV elicited by V3-peptide heptalysine octomers. (1992) (0)
- Human T-Lymphotropic Retroviruses and Their Role in Human Diseases (1986) (0)
- In Honour of Paul Kallós (1987) (0)
- A New Inducible RNAi Model for Cancer Target Validation In Vivo (2005) (0)
- (onc genes/RNA gel blotting/avian myeloblastosis virus/hematopoie promyelocytic leukemia cell line) (2016) (0)
- Human T-cell leukemia-lymphoma -integrated defective provirus and f) (human type C retrovirus/T-cell leukemia/molecular cloning/integi (2016) (0)
- Has Feminism Changed Science? (1999) (0)
- Ribozyme Gene Therapy Targeting Stem Cells for Human Immunodeficiency Virus Infection (2002) (0)
- Human leukemia viruses: the HTLV family and their role in human malignancies and immune deficiency disease (1985) (0)
- Fifth International Conference on AIDS : the Scientific and Social Challenge; symposium transcript; regulatory genes and viral genomic diversity (1989) (0)
- Two strains of baboon endogenous virus demonstrate a high degree of genetic conservation. (1983) (0)
- Cloning of Human Oncogenes (1985) (0)
- Review Development of new RNAi therapeutics (2007) (0)
- Retroviruses and Onc Genes in Human Leukemias and Lymphomas (1985) (0)
- COMPOSITIONS ET METHODES UTILES POUR LE TRAITEMENT DE L'HYPERGLYCEMIE (2006) (0)
- A RepeatSequence, GGGTTA,IsSharedbyDNA ofHuman Herpesvirus 6andMarek's Disease Virus (1988) (0)
- Molecular studies of human T cell leukemia/lymphotropic retroviruses. (1985) (0)
- Cell Cycle Dependence of Laminar Determination in Developing Neocortex (2008) (0)
- T-CELLS: cDNA CLONING AND CHARACTERIZATION (1984) (0)
- Abundant transcription ofacellular geneinTcells infected with humanT-cell leukemia-lymphoma (1983) (0)
- Polyadenylation of 35S RNA in vitro by a cytoplasmic particulate fraction from mouse myeloma. (1976) (0)
- High Level Transcription of a Human Gene in HTLV Positive T-Cells: cDNA Cloning and Characterization (1984) (0)
- Infection of Lymphocytes and Monocytes Kinetics of Expression of Multiply Spliced RNA in Early Human Immunodeficiency Virus Type (0)
- Reply to: Lack of evidence for involvement of known human retroviruses in multiple sclerosis (1986) (0)
- 546. Optimization of Expression of the SIV-Specific 9456 Ribozyme by the tRNAval PolIII Promoter within an MLV- or Lentiviral-Vector (2004) (0)
- Vectors and non-primate lentiviral packaging systems. (1998) (0)
- AIDS 92/93. Virology: overview. (1993) (0)
- COMPLEMENTARITY BETWEEN POTATO SPINDLE TUBER VIROID AND CELLULAR DNA: MEASUREMENT BY RNA-DNA HYBRIDIZATION (1976) (0)
- Human gene marker/therapy clinical protocols. (2000) (0)
- Mechanism of leukemogenesis by human T-cell leukemia virus types I and II: role of the lor gene. (1987) (0)
- Clinical value of quantitative imaging in patients with gastrointestinal liver metastases (0)
- Retroviruses and retroviral onc genes: possible role in human neoplasias and aplasias. (1984) (0)
- The human T-cell leukemia virus family, adult T cell leukemia, and AIDS. (1985) (0)
- Gene therapy for human immunodeficiency virus infection using stem cell transplantation (2000) (0)
- HIV-infected and AIDS ribotsyymigeeniterapia (1995) (0)
- virus type 2 vif gene. sequences in the human immunodeficiency Identification and mapping of inhibitory (2013) (0)
- MOLECULAR ANALYSIS OF HTLV-III AND DEVELOPMENT OF DIAGNOTIC AND VACCINE REAGENTS FOR AIDS (1987) (0)
- Chromosomal assignment ofthehumanhomologues offeline sarcoma virus andavian myeloblastosis virus onegenes (1982) (0)
- The development and applications of nonradioactive plate-formatted DNA-binding assay for Ku70/80, a multifunctional DNA-binding protein complex. (2004) (0)
- HTLV-III and the Etiology of AIDS (Part 1 of 2) (1986) (0)
- Leukemia-Lymphoma Virus ( HTLV ) : A Progress Report (2005) (0)
- Retrovirus sequences inaleukemic gibbon anditscontact: Evidence forpartial provirus inthenonleukemic gibbon (1979) (0)
- Structural organization andexpression ofhumanDNA sequences related tothetransforming geneofavian myeloblastosis virus (1983) (0)
- Interactions between 125-I-labelled RNA from RNA tumor viruses and RNA of other sources. (1976) (0)
- Breast irradiation in ductal carcinoma-in-situ (1997) (0)
- Pyrvinium targets the unfolded protein response to hypoglycemia and its anti-tumor activity is enhanced by novel combination strategies (2008) (0)
- The Family of Human T-Cell Leukemia Viruses and Their Role in the Cause of T-Cell Leukemia and AIDS (1985) (0)
- Murine Intracisternal TypeAParticles: aBiochemical Characterization (1975) (0)
- Retroviral Review@@@Retrovirus Biology and Human Disease (1990) (0)
- Prospects for AIDS vaccines (2002) (0)
- Help-Independent CTL Epitope The HIV-1 HLA-A 2-SLYNTVATL Is a (2004) (0)
- HIV Gene Therapy Using Hairpin Ribozymes in Hematopoietic Stem/Progenitor Cells (1999) (0)
- Therapy with ribozyme to the proliferating cell nuclear antigen-ribozyme and 5-fluorouracil of experimental choroidal neovascularization in rats. (2006) (0)
- The Cloning and Analyses of Human Cellular Genes Homologous to Retroviral Onc Genes (1983) (0)
- 13 – Molecular Mechanisms of Pathogenesis by HTLV-III (1987) (0)
- Cis- and Trans-Activation of HIV (1989) (0)
- Humanherpes virus-6 increases HIV-1expression in co-infected T cells vianuclear factors binding tothe HIV-1enhancer (1989) (0)
- MINI REVIEW Oncolytic virotherapy as a personalized cancer vaccine (2008) (0)
This paper list is powered by the following services:
Other Resources About Flossie Wong-Staal
What Schools Are Affiliated With Flossie Wong-Staal?
Flossie Wong-Staal is affiliated with the following schools:
